Neuroendocrine Colon Cancer Is A Very Aggressive Disease
One of the more aggressive and destructive forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that more often than not it is detected late into the advanced stages at which time it is more difficult to make treatments.
As the symptoms of neuroendocrine colon cancer take form only in the most advanced stages the chances of survival drops at an alarming rate. The polyps or tumours of the colon are always malignant, and mostly detected with distant metastases. In several surveys, the reports have revealed that most of the cases of neuroendocrine cancer end with the death of the patient.
Although the possibilities of neuroendocrine carcinoma in colon are very rare, if one is affected the health of the patient becomes worse than those who are suffering from adenocarcinoma.
Research reveals that the end results of this form of cancer stay the same with age, sex or tumour location. However, neuroendocrine colon carcinoma will depend heavily on the tumour’s stage. Standard cases have revealed that people in stage 1 and 2 of cancer usually do not suffer from neuroendocrine colon cancer. On the other hand, in several cases, if the tumour is in stage 3 or 4, it is a laborious and hard task the neuroendocrine colon carcinoma.
Unfortunately, medical science has few techniques to deal with this particular cancer. Among the more popular methods that doctors might use is immunohistochemical staining methods. This method assists doctors with coping with the seriousness of neuroendocrine colon cancer and assists doctors in deciding on the suitable medication and a way to treat it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. This involves staining of the tumour with the antibody A-80 which will help in the identification of the quantum of neuroendocrine differentiation and the extent of damage on the patient’s health.
Neuroendocrine colon carcinoma is cumbersome to deal with and in a certain study in which a number of patients suffered from colon carcinoma were extensively examined it was observed that the overall survival rate related to this disease was approximately seven months. In the later stages these rates decrease, to as low as five months or less. Most cases were at first found to be as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery is not a cent percent guaranteed treatment so surgery may not even provide a satisfactory cure. So it is critical to detect this disease on time and provide proper medication for it.
Today is the perfect time to find out more about . Join us .